Anatomical VATS Lobectomy & Targeted Lung Cancer Immunotherapy
Comprehensive multi-modality lung cancer treatment including anatomical lobectomy, segmentectomy, targeted therapy (EGFR/ALK/ROS1 inhibitors), and immune checkpoint inhibitors (Pembrolizumab) for NSCLC and SCLC.
Lung cancer treatment & surgery
Clinical Overview & Disease Information
Comprehensive multi-modality lung cancer treatment including anatomical lobectomy, segmentectomy, targeted therapy (EGFR/ALK/ROS1 inhibitors), and immune checkpoint inhibitors (Pembrolizumab) for NSCLC and SCLC.
Signs & Symptoms
- • Persistent dry cough lasting > 3 weeks
- • Vague chest discomfort worsening on deep inspiration
- • Unexplained fatigue
- • Hemoptysis (coughing up blood or blood-streaked sputum)
- • Unexplained weight loss > 10% and anorexia
- • Recurrent pneumonia / bronchitis in same lung lobe
- • Massive hemoptysis (> 200ml blood)
- • Severe stridor or acute superior vena cava (SVC) syndrome
Causes & Risk Factors
Primary Causes & Etiology
- Cigarette smoking and secondhand tobacco smoke exposure
- Occupational exposure to asbestos, silica, radon gas, and heavy metals
- EGFR exon 19 deletion / L858R or ALK gene rearrangements
Who is at Higher Risk?
- Smokers aged 50-80 with > 20 pack-year history, individuals with chronic COPD
Diagnostic Evaluation & Testing
| Diagnostic Test | Clinical Purpose / What It Shows |
|---|---|
| 18F-FDG Whole Body PET-CT Scan & High-Resolution CT Chest | Provides precise TNM staging (T-stage, N2/N3 nodal status, distant metastases) |
| EBUS-TBNA Mediastinal Biopsy & Next-Generation Sequencing (NGS) | Confirms histological subtype and profiles EGFR, ALK, ROS1, BRAF, and PD-L1 biomarkers |
Comprehensive Treatment Options
Uniportal VATS / da Vinci Robotic Anatomical Lobectomy & Systematic N2 Nodal Dissection
Keyhole thoracoscopic or robotic resection of tumor-bearing lung lobe with complete mediastinal lymphadenectomy.
Targeted Tyrosine Kinase Inhibitor (Osimertinib / Alectinib) & Immunotherapy
Biomarker-guided oral targeted therapy and anti-PD-L1 Pembrolizumab infusions.
Advanced Medical Technologies Available in Partner Hospitals
Possible Complications If Untreated
Recovery Timeline, Diet & Lifestyle Care
Recovery Timeline
| Procedure / Stage | Expected Recovery Duration |
|---|---|
| Thoracic ICU / HDU Recovery | 24 to 48 hours |
| Chest Drain Removal & Ward Ambulation | 3 to 5 days |
| Return to Work & Adjuvant Therapy | 3 to 4 weeks |
Recommended Post-Treatment Diet
- High protein, high calorie pulmonary recovery diet
- Hydration 2.5L/day
Essential Lifestyle Changes
- Perform incentive spirometry 10 times every hour while awake
- Daily walking starting Day 1 post-op
- Strict complete smoking cessation
Prevention & Long-Term Health
Frequently Asked Questions
Can early-stage lung cancer be cured with VATS surgery?
Yes, early-stage (Stage I & II) non-small cell lung cancer treated with VATS lobectomy has a 5-year survival rate exceeding 75-85%.
Top Recommended Specialists Available
Dr. Arun Chowdary Kotaru
Unit Head & Sr. Consultant - Respiratory Disease & Sleep Medicine - Heart & Lung Transplant
View Doctor Profile →
Dr. Mukesh Kumar Gupta
Head - Critical Care (Unit III) & Heart & Lung Transplant
View Doctor Profile →
Dr. Shweta Bansal
Unit Head & Sr. Consultant - Respiratory Disease & Sleep Medicine (Unit II)
View Doctor Profile →
Global Cost Comparison Matrix
| Procedure | USA (Avg) | India (ISG) | Turkey (Avg) | Thailand (Avg) |
|---|---|---|---|---|
| Lung cancer treatment & surgery | $55,000 | $6,500 | $14,000 | $16,000 |
Request Free Clinical Opinion & Cost Estimate
Upload your diagnostic reports or medical summary for a free review by leading specialists within 24-48 hours.
Get Free Treatment EstimateCommonly Prescribed Medications
- Osimertinib (Tagrisso) 80mg daily
- Pembrolizumab (Keytruda) 200mg IV
- Cefuroxime 1.5g IV
- Incentive Spirometer
International Patient Guide
- Passport & Visa
- Chest PET-CT Scan & Biopsy Histopathology Reports